Skip to main content

2024 Speakers

Corina Antal, PhD

Corina Antal, PhD

Assistant Professor of Pharmacology, Moores Cancer Center, UC San Diego

Aliza Apple, PhD

Aliza Apple, PhD
SSF Site Head, COO & Head of Lilly Gateway Labs West Coast

Joseph Califano, MD

Joseph Califano, MD

Director, Moores Cancer Center

Director, Hanna and Mark Gleiberman Head and Neck Cancer Center

 

John M. Carethers, MD

John M. Carethers, MD

Vice Chancellor for Health Sciences, UC San Diego

Ezra Cohen, MD

Ezra Cohen, MD

Chief Medical Officer of Oncology, Tempus Labs

Dmitry Gabrilovich, MD, PhD

Dmitry Gabrilovich, MD, PhD
Executive Director and Chief Scientist, Cancer Immunology, Astrazeneca

Jarret Glasscock, PhD

Jarret Glasscock, PhD
Founder and CEO, Cofactor Genomics

Jacob R. Haling, PhD

Jacob R. Haling, PhD
Head, Cancer Therapeutics, Novartis Biomedical Research

Fairooz Kabbinavar, MD, FACP

Fairooz Kabbinavar, MD, FACP
Chief Medical Officer, Cardiff Oncology

Dan Kaufman, MD, PhD

Dan Kaufman, MD, PhD
Professor of Medicine, Division of Regenerative Medicine, Director of Cell Therapy, Moores Cancer Center, UC San Diego

Rob Knight, PhD

Rob Knight, PhD

Director, Center for Microbiome Innovation, Professor of Pediatrics, Bioengineering, and Computer Science & Engineering, Moores Cancer Center, UC San Diego

Wolfe Family Endowed Chair in Microbiome Research, Rady Children's Hospital

Peter Krein, PhD

Peter Krein, PhD
Senior Vice President, Precision Medicine, Boundless Bio

Peter Kuhn, PhD

Peter Kuhn, PhD
Dean's Professor of Biological Sciences and Professor of Medicine, Biomedical Engineering, Aerospace & Mechanical Engineering, and Urology, University of Southern California

Brian McCloskey

Brian McCloskey
Patient Advocate and Co-Founder, Cancer Patient Lab

Mike Pellini, MD

Mike Pellini, MD
Managing Partner, Section 32

Teresa Ramirez Montagut, MD, PhD

Teresa Ramirez Montagut, MD, PhD
Executive Director, Oncology, Medical Affairs, Regeneron

Hunter Reed, MBA

Hunter Reed, MBA
Vice President, Science and Technology, Alexandria Venture Investments, Alexandria Real Estate Equities, Inc

David Schlaepfer, PhD

David Schlaepfer, PhD
Professor, Department of Obstetrics, Gynecology and Reproductive Services, Moores Cancer Center, UC San Diego

Laura Shawver, PhD

Laura Shawver, PhD
President and Chief Executive Officer, Capstan Therapeutics

Peter Smith, PhD

Peter Smith, PhD
Co-Founder, President, and Chief Executive Officer, Remix Therapeutics

Nicole Steinmetz, PhD

Nicole Steinmetz, PhD

Professor & Vice Chair, Department of NanoEngineering & Director of the Center for Nano-ImmunoEngineering & Co-Director of the Center for Engineering in Cancer, Moores Cancer Center, UC San Diego

Judith Varner, PhD

Judith Varner, PhD
Professor of Medicine and Pathology, Moores Cancer Center, UC San Diego

Dominique Verhelle, PhD

Dominique Verhelle, PhD
Co-Founder, CEO & CSO, NextRNA Therapeutics

Jonathan Weitz, PhD

Jonathan Weitz, PhD
Postdoctoral Researcher, Moores Cancer Center, UC San Diego

Kristin Yarema, PhD

Kristin Yarema, PhD
Chief Executive Officer, Poseida Therapeutics

Gene Yeo, PhD, MBA

Gene Yeo, PhD, MBA
Professor of Cellular and Molecular Medicine, Founding Member, Institute for Genomic Medicine, STEM Cell Program, Moores Cancer Center, UC San Diego

Ida Deichaite, PhD

Ida Deichaite, PhD

Director, Industry Relations, Moores Cancer Center

Assistant Professor, Radiation Medicine and Applied Sciences, UC San Diego